We know it’s a top priority for Congress, but a group of panelists speaking at an “emergency briefing” in the U.S. Senate this week hosted by an anti-FDA legal…

The FDA has approved a label expansion for Genmab and Johnson & Johnson’s multiple myeloma drug Darzalex three months ahead of schedule.

The FDA has lifted the partial clinical hold it placed on trials of Aduro Biotech’s CRS-207 cancer vaccine last month.

Let’s be honest, 2016 was a mess of year, and one that many of us will be happy to see the back of. It saw the loss of a series of beloved actors, actresses…

A law firm is suing Clovis Oncology over statements about the safety and efficacy of its now-scrapped lung cancer candidate rociletinib.

Spectrum has said in a SEC filing that the U.S. regulator has rejected its application for Qapzola (apaziquone) for bladder cancer.

J&J’s biotech arm has submitted its application to the FDA for its experimental med guselkumab in moderate to severe plaque psoriasis.

Erytech has withdrawn an application for approval of its tumor starvation drug in Europe after the regulator demanded more data.